ArticlePediatric blood & cancer2018

Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.

Judith G Villablanca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.